Insmed, Inc. (INSM)
118.07
-2.68
(-2.22%)
USD |
NASDAQ |
Nov 12, 16:00
117.75
-0.32
(-0.27%)
Pre-Market: 08:07
Insmed Total Assets (Quarterly) : 2.226B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.226B |
| June 30, 2026 | 2.103B |
| March 31, 2026 | 2.076B |
| December 31, 2025 | 2.265B |
| September 30, 2025 | 2.361B |
| June 30, 2025 | 2.480B |
| March 31, 2025 | 1.803B |
| December 31, 2024 | 2.025B |
| September 30, 2024 | 2.053B |
| June 30, 2024 | 1.810B |
| March 31, 2024 | 1.159B |
| December 31, 2023 | 1.330B |
| September 30, 2023 | 1.325B |
| June 30, 2023 | 1.439B |
| March 31, 2023 | 1.518B |
| December 31, 2022 | 1.656B |
| September 30, 2022 | 994.82M |
| June 30, 2022 | 1.053B |
| March 31, 2022 | 1.153B |
| December 31, 2021 | 1.244B |
| September 30, 2021 | 1.312B |
| June 30, 2021 | 1.230B |
| March 31, 2021 | 692.39M |
| December 31, 2020 | 796.16M |
| September 30, 2020 | 840.72M |
| Date | Value |
|---|---|
| June 30, 2020 | 885.36M |
| March 31, 2020 | 676.52M |
| December 31, 2019 | 742.30M |
| September 30, 2019 | 763.12M |
| June 30, 2019 | 802.78M |
| March 31, 2019 | 595.92M |
| December 31, 2018 | 604.56M |
| September 30, 2018 | 661.51M |
| June 30, 2018 | 724.24M |
| March 31, 2018 | 773.15M |
| December 31, 2017 | 462.05M |
| September 30, 2017 | 506.21M |
| June 30, 2017 | 165.64M |
| March 31, 2017 | 200.66M |
| December 31, 2016 | 237.96M |
| September 30, 2016 | 276.64M |
| June 30, 2016 | 299.68M |
| March 31, 2016 | 327.71M |
| December 31, 2015 | 356.56M |
| September 30, 2015 | 385.74M |
| June 30, 2015 | 408.51M |
| March 31, 2015 | 206.15M |
| December 31, 2014 | 230.86M |
| September 30, 2014 | 235.44M |
| June 30, 2014 | 150.11M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Gilead Sciences, Inc. | 51.41B |
| Incyte Corp. | 7.287B |
| Vertex Pharmaceuticals, Inc. | 32.74B |
| Regeneron Pharmaceuticals, Inc. | 44.41B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.500B |
| Shareholders Equity (Quarterly) | 726.21M |
| Debt to Equity Ratio | 1.032 |
| Current Ratio | 2.860 |
| Net Debt Paydown Yield | -0.01% |